marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-31-2024
Travere Therapeutics Balance Sheet 2011-2024 | TVTX
Annual Balance Sheet Travere Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
324 M | 318 M | 64.7 M | 131 M | 142 M | 115 M | -54.3 M | 3.42 M | 6.1 M | 65.6 M | -6 M | 21.1 K | 21 K |
Long Term Debt |
377 M | 376 M | 227 M | 215 M | 205 M | 195 M | 45.1 M | 44.4 M | 43.9 M | 43.3 M | - | - | - |
Long Term Debt Current |
4.91 M | 4.43 M | 3.91 M | 357 K | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 288 M | 286 M | 142 M | 134 M | 127 M | 65.2 M | 3.6 M | - | - |
Total Current Liabilities |
178 M | 142 M | 124 M | 92.7 M | 95.4 M | 105 M | 85.7 M | 83.3 M | 85.8 M | 108 M | 36.6 M | 5.8 M | 556 K |
Total Liabilities |
588 M | 630 M | 475 M | 396 M | 384 M | 391 M | 227 M | 218 M | 212 M | 173 M | 38.8 M | 67 K | 64.2 K |
Deferred Revenue |
7.1 M | 12 M | 16.3 M | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-1.13 B | -1.01 B | -766 M | -586 M | -416 M | -270 M | -178 M | -113 M | -65.2 M | -179 M | -67.4 M | -136 K | -121 K |
Total Assets |
789 M | 673 M | 777 M | 607 M | 605 M | 709 M | 520 M | 525 M | 512 M | 135 M | 20.5 M | 3.91 K | 3.96 K |
Cash and Cash Equivalents |
58.2 M | 61.7 M | 166 M | 84.8 M | 62.4 M | 103 M | 99.4 M | 41 M | 37.8 M | 18.2 M | 6 M | 11.4 K | 10.1 K |
Book Value |
201 M | 42.9 M | 302 M | 211 M | 221 M | 318 M | 293 M | 308 M | 300 M | -37.3 M | -18.3 M | -63.1 K | -60.3 K |
Total Shareholders Equity |
201 M | 42.9 M | 302 M | 211 M | 221 M | 318 M | 293 M | 308 M | 300 M | -37.3 M | -19.7 M | -3.41 M | -536 K |
All numbers in USD currency
Quarterly Balance Sheet Travere Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
310 M | 378 M | 378 M | 377 M | 377 M | 376 M | 376 M | 376 M | 375 M | - | 374 M | 227 M | 224 M | 221 M | 218 M | 215 M | 215 M | 215 M | 215 M | 205 M | 205 M | 205 M | 205 M | 195 M | 22.6 M | 195 M | 195 M | 45.1 M | 45.1 M | 45.1 M | - | 44.4 M | - | - | - | 43.8 M | 46 M | 91 M | 91 M | 43.3 M | 91 M | 91 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
535 M | 536 M | 589 M | 588 M | 553 M | 620 M | 619 M | 630 M | 626 M | - | 620 M | 475 M | 468 M | 414 M | 401 M | 396 M | 396 M | 396 M | 396 M | 384 M | 384 M | 384 M | 384 M | 391 M | 391 M | 391 M | 391 M | 227 M | 227 M | 227 M | 227 M | 218 M | 218 M | 218 M | 218 M | 212 M | 212 M | 212 M | 212 M | 173 M | 173 M | 173 M | 173 M | 40.2 M | 38.8 M | 38.8 M | 38.8 M | 5.8 M | - | - | 5.8 M | - | - | - | - |
Deferred Revenue |
3.8 M | 5.38 M | 6.46 M | 7.1 M | 8.96 M | 10.2 M | 11 M | 12 M | 11.4 M | - | 14.2 M | 16.3 M | 16.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-1.39 B | -1.33 B | -1.26 B | -1.13 B | -1.04 B | -1.19 B | -1.1 B | -1.01 B | -948 M | - | -812 M | -766 M | -714 M | -679 M | -640 M | -586 M | -586 M | -586 M | -586 M | -416 M | -416 M | -416 M | -416 M | -270 M | -270 M | -270 M | -270 M | -178 M | -178 M | -178 M | -178 M | -113 M | -113 M | -113 M | -113 M | -65.2 M | -65.2 M | -65.2 M | -65.2 M | -179 M | -179 M | -179 M | -179 M | -68.2 M | -67.4 M | - | - | -33.6 M | -33.6 M | -140 K | -136 K | -132 K | - | - | -121 K |
Total Assets |
504 M | 551 M | 664 M | 789 M | 833 M | 736 M | 808 M | 673 M | 726 M | - | 828 M | 777 M | 775 M | 747 M | 764 M | 607 M | 607 M | 607 M | 607 M | 605 M | 605 M | 605 M | 605 M | 709 M | 709 M | 709 M | 709 M | 520 M | 520 M | 520 M | 520 M | 525 M | 525 M | 525 M | 525 M | 512 M | 512 M | 512 M | 512 M | 135 M | 135 M | 135 M | 135 M | 20.5 M | 20.5 M | 20.5 M | 20.5 M | 2.39 M | 2.39 M | 2.39 M | 2.39 M | 19.6 K | - | - | - |
Cash and Cash Equivalents |
36.4 M | 32.3 M | 43.3 M | 58.2 M | 144 M | 70.9 M | 161 M | 61.7 M | 151 M | 180 M | 257 M | 166 M | 150 M | 83.3 M | 148 M | 84.8 M | 84.8 M | 84.8 M | 84.8 M | 62.4 M | 62.4 M | 62.4 M | 62.4 M | 103 M | 103 M | 103 M | 103 M | 99.4 M | 99.4 M | 99.4 M | 99.4 M | 41 M | 41 M | 41 M | 41 M | 37.8 M | 37.8 M | 37.8 M | 37.8 M | 18.2 M | 18.2 M | 18.2 M | 18.2 M | 6 M | 6 M | 6 M | 6 M | 11 K | 11.4 K | 11.4 K | 11.4 K | 10.1 K | 3.89 K | 3.93 K | - |
Book Value |
-30.5 M | 15.1 M | 74.1 M | 201 M | 280 M | 116 M | 189 M | 42.9 M | 101 M | - | 208 M | 302 M | 307 M | 332 M | 363 M | 211 M | 211 M | 211 M | 211 M | 221 M | 221 M | 221 M | 221 M | 318 M | 318 M | 318 M | 318 M | 293 M | 293 M | 293 M | 293 M | 308 M | 308 M | 308 M | 308 M | 300 M | 300 M | 300 M | 300 M | -37.3 M | -37.3 M | -37.3 M | -37.3 M | -19.7 M | -18.3 M | -18.3 M | -18.3 M | -3.41 M | 2.39 M | 2.39 M | -3.41 M | 19.6 K | - | - | - |
Total Shareholders Equity |
-30.5 M | 15.1 M | 74.1 M | 201 M | 280 M | 116 M | 189 M | 42.9 M | 101 M | 157 M | 208 M | 302 M | 307 M | 332 M | 363 M | 211 M | 211 M | 211 M | 211 M | 221 M | 221 M | 221 M | 221 M | 318 M | 318 M | 318 M | 318 M | 293 M | 293 M | 293 M | 293 M | 308 M | 308 M | 308 M | 308 M | 300 M | 300 M | 300 M | 300 M | -37.3 M | -37.3 M | -37.3 M | -37.3 M | -19.7 M | -18.3 M | -18.3 M | -18.3 M | -3.41 M | -3.41 M | -3.41 M | -3.41 M | -536 K | - | - | - |
All numbers in USD currency